These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34957356)

  • 1. The Utility and Potential of Mathematical Models in Predicting Fibrinolytic Outcomes.
    Bannish BE; Hudson NE
    Curr Opin Biomed Eng; 2021 Dec; 20():. PubMed ID: 34957356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood clot contraction differentially modulates internal and external fibrinolysis.
    Tutwiler V; Peshkova AD; Le Minh G; Zaitsev S; Litvinov RI; Cines DB; Weisel JW
    J Thromb Haemost; 2019 Feb; 17(2):361-370. PubMed ID: 30582674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biochemical and physical process of fibrinolysis and effects of clot structure and stability on the lysis rate.
    Weisel JW; Litvinov RI
    Cardiovasc Hematol Agents Med Chem; 2008 Jul; 6(3):161-80. PubMed ID: 18673231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling fibrinolysis: 1D continuum models.
    Bannish BE; Keener JP; Woodbury M; Weisel JW; Fogelson AL
    Math Med Biol; 2014 Mar; 31(1):45-64. PubMed ID: 23220467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MASP-1 of the complement system alters fibrinolytic behaviour of blood clots.
    Jenny L; Noser D; Larsen JB; Dobó J; Gál P; Pál G; Schroeder V
    Mol Immunol; 2019 Oct; 114():1-9. PubMed ID: 31325724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microscale structural changes of individual fibrin fibers during fibrinolysis.
    Lynch SR; Laverty SM; Bannish BE; Hudson NE
    Acta Biomater; 2022 Mar; 141():114-122. PubMed ID: 35007782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and biophysical conditions for blood clot lysis.
    Sabovic M; Blinc A
    Pflugers Arch; 2000; 440(5 Suppl):R134-6. PubMed ID: 11005642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and Physical Mechanisms of Fibrinolysis and Thrombolysis from Mathematical Modeling and Experiments.
    Bannish BE; Chernysh IN; Keener JP; Fogelson AL; Weisel JW
    Sci Rep; 2017 Aug; 7(1):6914. PubMed ID: 28785035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basic mechanisms and regulation of fibrinolysis.
    Longstaff C; Kolev K
    J Thromb Haemost; 2015 Jun; 13 Suppl 1():S98-105. PubMed ID: 26149056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and biophysical conditions for blood clot lysis.
    Šabovič M; Blinc A
    Pflugers Arch; 2000 Jan; 440(Suppl 1):R134-R136. PubMed ID: 28008511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of transport parameters and enzyme kinetics of the fibrinolytic system on thrombolysis: mathematical modelling of two idealised cases.
    Zidansek A; Blinc A
    Thromb Haemost; 1991 May; 65(5):553-9. PubMed ID: 1831302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling fibrinolysis: a 3D stochastic multiscale model.
    Bannish BE; Keener JP; Fogelson AL
    Math Med Biol; 2014 Mar; 31(1):17-44. PubMed ID: 23220403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of fibrin: impact on clot stability.
    Weisel JW
    J Thromb Haemost; 2007 Jul; 5 Suppl 1():116-24. PubMed ID: 17635717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redistribution of TPA Fluxes in the Presence of PAI-1 Regulates Spatial Thrombolysis.
    Shibeko AM; Chopard B; Hoekstra AG; Panteleev MA
    Biophys J; 2020 Aug; 119(3):638-651. PubMed ID: 32653051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transport processes in fibrinolysis and fibrinolytic therapy.
    Blinc A; Francis CW
    Thromb Haemost; 1996 Oct; 76(4):481-91. PubMed ID: 8902982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole blood clots are more resistant to lysis than plasma clots--greater efficacy of rivaroxaban.
    Varin R; Mirshahi S; Mirshahi P; Klein C; Jamshedov J; Chidiac J; Perzborn E; Mirshahi M; Soria C; Soria J
    Thromb Res; 2013 Mar; 131(3):e100-9. PubMed ID: 23313382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of fibroblasts in organization and degradation of a fibrin clot.
    Mirshahi M; Azzarone B; Soria J; Mirshahi F; Soria C
    J Lab Clin Med; 1991 Apr; 117(4):274-81. PubMed ID: 2010668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The suboptimal fibrinolytic response in COVID-19 is dictated by high PAI-1.
    Whyte CS; Simpson M; Morrow GB; Wallace CA; Mentzer AJ; Knight JC; Shapiro S; Curry N; Bagot CN; Watson H; Cooper JG; Mutch NJ
    J Thromb Haemost; 2022 Oct; 20(10):2394-2406. PubMed ID: 35780481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxynitrite may affect fibrinolysis via the reduction of platelet-related fibrinolysis resistance and alteration of clot structure.
    Misztal T; Rusak T; Brańska-Januszewska J; Ostrowska H; Tomasiak M
    Free Radic Biol Med; 2015 Dec; 89():533-47. PubMed ID: 26454084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rearrangements of the fibrin network and spatial distribution of fibrinolytic components during plasma clot lysis. Study with confocal microscopy.
    Sakharov DV; Nagelkerke JF; Rijken DC
    J Biol Chem; 1996 Jan; 271(4):2133-8. PubMed ID: 8567670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.